Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Analysis of Diffusion Tensor Parameters in Spinocerebellar Ataxia Type 3 and Type 10 Patients
Movement Disorders
Movement Disorders Posters (7:00 AM-5:00 PM)
024

To analyze changes observed in DTI parameters and correlate these to clinical findings in SCA3 and SCA10 patients.

There is a dearth of studies of spinocerebellar ataxias (SCAs) and diffusion tensor magnetic resonance imaging (DTI).

SCA3 (n=19) and SCA10 (n=18) patients were compared with a similar number of controls and assessed clinically and with the scale for the assessment and rating of ataxia (SARA) before undergoing the same MRI protocol. TRACULA (TRActs Constrained by UnderLying Anatomy) software was used to analyze the DTI metrics FA, AD, RD and MD.

More white matter fiber tracts with changes in diffusivity were found in SCA3 patients than in SCA10 patients. There was a reduction in AD in altered fiber tracts in SCA3 and a greater increase in RD in SCA10. In the SCA3 patients, FA was reduced in the corticospinal tract (CST) and inferior longitudinal fasciculus (ILF), but this was not observed in the SCA10 patients. SARA score was correlated with DTI findings in SCA3 but not in SCA10.

Changes were observed in DTI for both SCA3 and SCA10 but were more widespread in SCA3. Our finding of myelin-sheath changes in SCA10 and secondary axonal changes in SCA3 may reflect the more rapid, aggressive clinical course of SCA3.

Authors/Disclosures

PRESENTER
No disclosure on file
Walter O. Arruda, MD, PhD Dr. Arruda has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Tetsuo Ashizawa, MD, FÂé¶¹´«Ã½Ó³»­ (Methodist Hospital Research Institute) An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Carlos Henrique F. Camargo, MD, PhD, MSc, FÂé¶¹´«Ã½Ó³»­ (Inovare Serviços de Saude Ltda.) Dr. Camargo has nothing to disclose.
Helio Afonso G. Teive, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Teive has nothing to disclose.